Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in GILD — Gilead Sciences, Inc.

CIK 886982 NEW YORK, NY
Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,542,158,873
+$467,875,430 QoQ
Shares Held
11,065,214
+26.4% QoQ
Ownership
0.891%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.0117252138097.ToString("F0")% Shared 0.049759543737699065.ToString("F0")% None 2.9385152424526084.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Mar 31, 2026
CallValue
$49,406,665
CallShares
354,500
PutValue
$17,044,951
PutShares
122,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $25,307,344,615 across 17 Drug Manufacturers - General names. GILD ranks #6 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 6,340,865 $5,832,137,397
2 JNJ
Johnson & Johnson
 18,057,047 $4,413,864,566
3 ABBV
AbbVie Inc.
 15,145,279 $3,293,946,727
4 MRK
Merck & Co., Inc.
 20,133,379 $2,421,844,158
5 AZN
Astrazeneca PLC
 10,605,842 $2,091,684,157
6 GILD
Gilead Sciences, Inc.
This page 		11,065,214 $1,542,158,873
7 AMGN
Amgen Inc
 4,219,989 $1,484,803,127
8 PFE
Pfizer Inc
 47,105,556 $1,322,724,010

All Filings in GILD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,542,158,873 11,065,214
2026-03-31 $17,044,951 122,300
2026-03-31 $49,406,665 354,500
2025-12-31 $1,074,283,443 8,752,513
2025-12-31 $1,804,278 14,700
2025-12-31 $5,842,424 47,600
2025-09-30 $790,520,022 7,121,802
2025-09-30 $1,554,000 14,000
2025-09-30 $3,108,000 28,000
2025-06-30 $692,090,451 6,242,360
2025-06-30 $997,830 9,000
2025-06-30 $997,830 9,000
2025-03-31 $760,393,372 6,786,197
2025-03-31 $896,400 8,000
2024-12-31 $688,041,128 7,448,751
2024-12-31 $923,700 10,000
2024-12-31 $3,934,962 42,600
2024-09-30 $838,400 10,000
2024-09-30 $598,918,417 7,143,588
2024-09-30 $3,571,584 42,600
2024-06-30 $3,951,936 57,600
2024-06-30 $629,827,035 9,179,814
2024-06-30 $2,744,400 40,000
2024-03-31 $380,206,980 5,190,539
2024-03-31 $4,219,200 57,600
2024-03-31 $2,930,000 40,000
2023-12-31 $2,495,108 30,800
2023-12-31 $781,067,390 9,641,617
2023-12-31 $6,351,184 78,400
2023-09-30 $4,743,702 63,300
2023-09-30 $831,708,023 11,098,319
2023-09-30 $6,991,902 93,300
2023-06-30 $9,533,559 123,700
2023-06-30 $819,400,761 10,631,903
2023-06-30 $8,069,229 104,700
2023-03-31 $870,133,269 10,487,324
2023-03-31 $14,918,006 179,800
2023-03-31 $15,332,856 184,800
2022-12-31 $804,179,353 9,367,261
2022-12-31 $10,696,910 124,600
2022-12-31 $11,126,160 129,600
2022-09-30 $491,211,743 7,962,583
2022-09-30 $1,856,869 30,100
2022-09-30 $1,499,067 24,300
2022-06-30 $8,257,816 133,600
2022-06-30 $1,600,879 25,900
2022-06-30 $528,188,824 8,545,362
2022-03-31 $10,974,470 184,600
2022-03-31 $434,132,195 7,302,476
2022-03-31 $5,380,225 90,500

Report a Problem

Category
Description
Email (optional, for follow-up)